What: Doctors Speak Out, a series of conversations with leading Georgetown University Medical Center (GUMC) physicians and researchers on current health issues. The latest installment, the third in the ongoing series, is entitled Forgetting to Remember: Our Mind Matters. It will explore cutting edge research into Alzheimer’s disease at GUMC, including a clinical trial at our Memory Disorders Program that is part of the nation’s first-ever testing gene-based treatment. GUMC’s brand of ensemble science aims at breakthroughs, such as cracking the genetic codes of Alzheimer’s disease.
When: Thursday, March 25, 2010; 12:00 pm-1:30 pm
[GUMC physicians will be available for one-on-one media interviews at 2:00 pm]
Note: This event is by invitation only.
Where: Georgetown University Leavey Conference Center (On Georgetown University campus), Reservoir Road, NW, Washington, DC 20057
Who: GUMC physicians and researchers expert in neurodegenerative diseases, gene therapy, genetic risks of Alzheimer’s, and prevention and intervention strategies in Alzheimer’s treatment. Veteran journalist Judy Woodruff of PBS’ The News Hour will moderate.
Howard J. Federoff, MD, PhD, GUMC’s executive vice president for health sciences, is a highly accomplished scientist-physician whose research focuses on gene therapy and neurodegenerative diseases, including Alzheimer’s Disease. He works to define the underlying microscopic principles that cause disease in the brain, then uses this knowledge to develop prevention strategies and early intervention therapies. Federoff holds numerous patents, has published extensively and serves on the editorial boards of five leading peer-reviewed journals. A founding scientist of several biotech companies, he also serves as chair of the National Institutes of Health Recombinant DNA Advisory Committee.
R. Scott Turner, MD, PhD, director, Memory Disorders Program, is an expert in the diagnosis and treatment of people with memory disorders and other neurodegenerative dementias, including Alzheimer's Disease. Turner’s research includes studies of how a protein precursor breaks down and how resveratrol, a substance found in red wine, impacts mild to moderate cases of the disease. More than a dozen clinical trials involving about 100 patients are underway at the Memory Disorders Program, in partnership with MedStar’s Georgetown University Hospital.
G. William Rebeck, PhD, director, Interdisciplinary Program in Neuroscience, is an expert on genetic risk factors for Alzheimer’s disease. Rebeck's work on APOE, which is involved in cholesterol transport in the body, has clarified the role of family history in Alzheimer's. Rebeck’s laboratory is pointing to new therapeutic approaches to preventing Alzheimer's. His research is also focused on how the brain responds to damage, such as traumatic brain injury.
Judy Woodruff, senior correspondent/co-anchor of PBS NewsHour, is a
respected, award-winning broadcast journalist who has been on the frontlines
of national news for more than three decades at PBS, NBC and CNN. She
regularly co-anchors PBS NewsHour and also anchored PBS’ award-winning
weekly documentary series, Frontline with Judy Woodruff from 1984 to 1990.
At NBC, Woodruff served as White House correspondent and chief Washington
correspondent for Today. At CNN, Woodruff was senior correspondent and
anchored Inside Politics. Woodruff’s many awards include the Edward R. Murrow
Lifetime Achievement Award. A founding co-chair of the International Women’s
Media Foundation, she serves on numerous boards. She has taught at Duke University and was a fellow at Harvard University.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown’s affiliation with MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.